164 related articles for article (PubMed ID: 32828944)
1. Raloxifene inhibits IL-6/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE
Luo P; Shi W; Wang Y; Ma H; Liu T; Yan D; Huo S; Guo J; Wang M; Li C; Lin J; Zhang C; Li S; Lv J; Lin L
Life Sci; 2020 Nov; 261():118304. PubMed ID: 32828944
[TBL] [Abstract][Full Text] [Related]
2. Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6/IL-6R/STAT3 signaling.
Luo P; Wang Y; Zhao C; Guo J; Shi W; Ma H; Liu T; Yan D; Huo S; Wang M; Li C; Lin J; Li S; Lv J; Zhang C; Lin L
Eur J Pharmacol; 2021 Feb; 893():173822. PubMed ID: 33347820
[TBL] [Abstract][Full Text] [Related]
3. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
[TBL] [Abstract][Full Text] [Related]
4. Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis.
Jones GW; McLeod L; Kennedy CL; Bozinovski S; Najdovska M; Jenkins BJ
Atherosclerosis; 2015 Feb; 238(2):321-8. PubMed ID: 25545330
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
[TBL] [Abstract][Full Text] [Related]
6. Suppression of PAPP-A mitigates atherosclerosis by mediating macrophage polarization via STAT3 signaling.
Wang G; Liu X; Li X; Zhao Y
Biochem Biophys Res Commun; 2021 Mar; 543():29-37. PubMed ID: 33508770
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3.
Wang J; Li P; Xu X; Zhang B; Zhang J
Front Immunol; 2020; 11():907. PubMed ID: 32655542
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista.
Shi W; Yan D; Zhao C; Xiao M; Wang Y; Ma H; Liu T; Qin H; Zhang C; Li C; Lin J; Li S; Lv J; Lin L
Biochem Biophys Res Commun; 2017 Sep; 491(1):159-165. PubMed ID: 28711499
[TBL] [Abstract][Full Text] [Related]
9. Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene.
Huo S; Shi W; Ma H; Yan D; Luo P; Guo J; Li C; Lin J; Zhang C; Li S; Lv J; Lin L
Oxid Med Cell Longev; 2021; 2021():6699054. PubMed ID: 33824698
[TBL] [Abstract][Full Text] [Related]
10. Peperomin E (PepE) protects against high fat diet-induced atherosclerosis in Apolipoprotein E deficient (ApoE
Yan J; Li M; Wang XD; Lu ZY; Ni XL
Biomed Pharmacother; 2018 Sep; 105():862-869. PubMed ID: 30021379
[TBL] [Abstract][Full Text] [Related]
11. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
[TBL] [Abstract][Full Text] [Related]
12. Longxuetongluo capsule inhibits atherosclerosis progression in high-fat diet-induced ApoE
Zheng J; Liu B; Lun Q; Gu X; Pan B; Zhao Y; Xiao W; Li J; Tu P
Atherosclerosis; 2016 Dec; 255():156-163. PubMed ID: 27591127
[TBL] [Abstract][Full Text] [Related]
13. Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: An insight into PI3K/Akt activation and STAT3 signaling pathways.
Qin M; Luo Y; Meng XB; Wang M; Wang HW; Song SY; Ye JX; Pan RL; Yao F; Wu P; Sun GB; Sun XB
Vascul Pharmacol; 2015 Jul; 70():23-34. PubMed ID: 25849952
[TBL] [Abstract][Full Text] [Related]
14. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
15. Equol Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice by Inhibiting Endoplasmic Reticulum Stress via Activation of Nrf2 in Endothelial Cells.
Zhang T; Hu Q; Shi L; Qin L; Zhang Q; Mi M
PLoS One; 2016; 11(12):e0167020. PubMed ID: 27907038
[TBL] [Abstract][Full Text] [Related]
16. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
17. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhizin, a High-Mobility Group Box 1 Inhibitor, Improves Lipid Metabolism and Suppresses Vascular Inflammation in Apolipoprotein E Knockout Mice.
Ding JW; Luo CY; Wang XA; Zhou T; Zheng XX; Zhang ZQ; Yu B; Zhang J; Tong XH
J Vasc Res; 2018; 55(6):365-377. PubMed ID: 30650406
[TBL] [Abstract][Full Text] [Related]
19. Danhong Injection Attenuates High-Fat-Induced Atherosclerosis and Macrophage Lipid Accumulation by Regulating the PI3K/AKT Insulin Pathway.
Zhou M; Ren P; Li S; Kang Q; Zhang Y; Liu W; Shang J; Gong Y; Liu H
J Cardiovasc Pharmacol; 2019 Aug; 74(2):152-161. PubMed ID: 31306371
[TBL] [Abstract][Full Text] [Related]
20. Asperlin Inhibits LPS-Evoked Foam Cell Formation and Prevents Atherosclerosis in ApoE
Zhou Y; Chen R; Liu D; Wu C; Guo P; Lin W
Mar Drugs; 2017 Nov; 15(11):. PubMed ID: 29135917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
